From: In-depth phenotyping for clinical stratification of Gaucher disease
 |  | Hazard ratio | P-value | [95% CI] | |
---|---|---|---|---|---|
1st fragility fracture | Splenectomy | 2.83 | 0.01 | 1.33 | 5.99 |
N = 247 | Gender effect | 1.04 | 0.91 | 0.52 | 2.07 |
Multiple fragility fractures* | Splenectomy | 5.78 | <0.0001 | 2.32 | 14.42 |
N = 247 | Gender effect | 0.59 | 0.17 | 0.28 | 1.24 |
1st osteonecrosis | Splenectomy | 2.95 | <0.0001 | 1.74 | 5.00 |
N = 246 | Gender | 0.80 | 0.37 | 0.48 | 1.31 |
Osteonecrosis events* | Splenectomy | 3.32 | <0.0001 | 1.98 | 5.56 |
N = 246 | Gender effect | 0.95 | 0.83 | 0.59 | 1.53 |
Presence of Erlenmeyer flask deformity | Splenectomy | 0.98 | 0.95 | 0.59 | 1.64 |
N = 248 | Gender effect | 0.80 | 0.34 | 0.50 | 1.27 |
Presence of lytic lesions | Splenectomy | 2.70 | 0.12 | 0.76 | 9.52 |
N = 248 | Gender effect | 0.26 | 0.08 | 0.06 | 1.16 |
Orthopaedic surgery | Splenectomy | 1.99 | 0.01 | 1.15 | 3.44 |
N = 244 | Gender effect | 0.84 | 0.52 | 0.50 | 1.41 |